GENOME EDITING TECHNIQUES REGULATORY ADVOCACY STRATEGY: PROSPECTS, STATUS, AND CHALLENGES FOR AN ADVANCED BIOTECHNOLOGY APPLICATION IN INDONESIAN AGRICULTURE INDUSTRY

• Main Author: Aulia Rizky Parijadi, Anjaritha
• Format: Theses
• Language: Indonesia
• Subjects: Manajemen umum
• Online Access: https://digilib.itb.ac.id/gdl/view/75295
• Institution: Institut Teknologi Bandung

The development of biotechnology in the last decade led the advanced biotechnology application through genome editing technology. Genome editing as a new technology offers the simple and sophisticated technology which could edit the agricultural crops into the desired traits. The technology acceptance shown through several policies applied in several countries that treat the technology as a new plant breeding technology. The competences of Indonesia on adopting the technology are being challenged to see the capability of Indonesia through the regulatory advocacy process. Additionally, the high cost offered by Genetically Modified (GM) products development (R&D processes, and regulatory activities) has become a challenge for more than decades on technology enablement worldwide, especially in Indonesia where hundreds of studies on genetically modified product of several Indonesian commodities have been conducted by Indonesian researcher in the last decade without being registered as a variety to be utilized by farmers. Furthermore, the challenges of technology acceptance are described in downstream level specifically in agriculture industry level, furthermore on the consumer level. Favorable regulatory environment for gene editing should be offered as positive support from government on technology adoption in Indonesia. Strategic regulatory advocacy planning should be established to drive the genome editing product registration process policy into positive direction which favorable for industry implementation and drive the positive sentiment of gaining the clarity on regulatory status as a driver for plant breeding innovation in the future. To oversee Indonesia readiness on genome editing technology adoption, innovation sector stakeholder should become the center of excellence where the innovation as an research output can be utilized further by the downstream level such as industry, farmer, and consumer. Resource based view of Indonesia capability through internal analysis of selected innovation-sector stakeholder (BRIN/NARI) were being comprehensively examined empirically. The results of resources indicate Indonesia capability was compared to seek the competitiveness with other countries who have adopted the technology. Cost-leadership was chosen as a country level strategy where the technology offers the low-cost budget (for research and development activities and regulatory process) and timely efficient. Through cost-leadership, the financial condition that observed as a threats of Indonesia capability to adopt and has a chance to have positive regulatory environment can be aided fairly. Furthermore, strategic alliance through country governance initiates the robust structure among key stakeholder who related with the genome editing technology. Strategic alliance also offered the collaboration between Indonesian researchers and other country researchers from reputable institutions. From the robust collaboration in strategic alliance, the updated innovation is expected to increase which lead to the good reputation of country and governance system for biotechnology product. Good governance for biotechnology, will bring a specific trust from stakeholders and make the stakeholder alliance a trustable partner and a center of knowledge for the upcoming technology. The robust strategy is expected to bring a positive environment for genome editing technology adoption technology and reach the above-average results compare to other country adoption process. Technology adoption and dynamic regulatory environment necessity are required to have a sustainable agriculture practice in Indonesia.